The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis
- PMID: 16256385
- DOI: 10.1016/j.ghir.2005.09.001
The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis
Abstract
Objective: Insulin-like growth factor I (IGF-I) levels and cognitive functioning decrease with aging. Several studies report positive correlations between IGF-I levels and cognitive functioning in healthy elderly. However, because of controversial data no definitive conclusions can be drawn concerning the relation between IGF-I and cognition. Therefore, we carried out a meta-analysis on studies that report on the relation between IGF-I and cognition in healthy elderly.
Design: We searched the electronic databases for articles about IGF-I and cognition. Studies from 1985 to January 2005 are included. Two reviewers independently extracted data on study design and cognitive outcomes. Thirteen studies on IGF-I and cognition in elderly, with a total number of 1981 subjects, met the inclusion criteria. On the data from these studies meta-analyses were carried out by means of the program Comprehensive Meta-analysis using a random effects model.
Results: Pooled effects show that IGF-I levels in healthy elderly have a positive correlation with cognitive functioning, which appeared to be mainly measured with the mini mental state examination (MMSE). The effect size is 0.6, which indicates the presence of a large positive relationship between IGF and cognition in healthy elderly.
Conclusion: These meta-analyses showed an overall relationship between IGF-I levels and cognitive functioning in healthy elderly. Further studies should be performed to clarify the role of IGF-I substitution in preserving cognitive functions with aging.
Similar articles
-
Free insulin-like growth factor-I and cognitive function in older persons living in community.Growth Horm IGF Res. 2007 Feb;17(1):58-66. doi: 10.1016/j.ghir.2006.11.001. Epub 2007 Jan 8. Growth Horm IGF Res. 2007. PMID: 17208483
-
Levels of plasma insulin-like growth factor I (IGF I), IGF II, IGF binding proteins, type 1 IGF receptor and growth hormone binding protein in community-dwelling elderly subjects with no malnutrition and no inflammation.J Nutr Health Aging. 2003;7(4):267-73. J Nutr Health Aging. 2003. PMID: 12917753
-
Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.Pediatrics. 2005 Nov;116(5):e681-6. doi: 10.1542/peds.2004-2390. Pediatrics. 2005. PMID: 16263982
-
Insulin-like growth factor-I, cognition and brain aging.Eur J Pharmacol. 2004 Apr 19;490(1-3):87-95. doi: 10.1016/j.ejphar.2004.02.047. Eur J Pharmacol. 2004. PMID: 15094076 Review.
-
Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan.Prog Neurobiol. 2009 Nov;89(3):256-65. doi: 10.1016/j.pneurobio.2009.07.008. Epub 2009 Aug 7. Prog Neurobiol. 2009. PMID: 19665513 Review.
Cited by
-
Toward identifying the effects of the specific components of Mindfulness-Based Stress Reduction on biologic and emotional outcomes among older adults.J Altern Complement Med. 2013 Oct;19(10):787-92. doi: 10.1089/acm.2012.0028. Epub 2013 Feb 5. J Altern Complement Med. 2013. PMID: 23383976 Free PMC article.
-
Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study.PLoS One. 2016 Apr 26;11(4):e0154450. doi: 10.1371/journal.pone.0154450. eCollection 2016. PLoS One. 2016. PMID: 27115487 Free PMC article.
-
The Association between IGF-1 Polymorphisms, IGF-1 Serum Levels, and Cognitive Functions in Healthy Adults: The Amsterdam Growth and Health Longitudinal Study.Int J Endocrinol. 2014;2014:181327. doi: 10.1155/2014/181327. Epub 2014 Jul 10. Int J Endocrinol. 2014. PMID: 25114679 Free PMC article.
-
Insulin-like growth factor I sensitization rejuvenates sleep patterns in old mice.Geroscience. 2022 Aug;44(4):2243-2257. doi: 10.1007/s11357-022-00589-1. Epub 2022 May 23. Geroscience. 2022. PMID: 35604612 Free PMC article.
-
Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.Age (Dordr). 2007 Sep;29(2-3):55-67. doi: 10.1007/s11357-007-9030-3. Epub 2007 May 12. Age (Dordr). 2007. PMID: 19424831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous